{"name":"e-Therapeutics PLC","slug":"e-therapeutics-plc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Dexanabinol Dose Level 3","genericName":"Dexanabinol Dose Level 3","slug":"dexanabinol-dose-level-3","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Dexanabinol Dose Level 3","genericName":"Dexanabinol Dose Level 3","slug":"dexanabinol-dose-level-3","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPWGdabzJ4dnlUYkNmYlQwek51N0Z3Nm9kd3pwaUdaZDRYQUx6cXBqZnhOZTk1STdUZGdzTXJXZHVRVFkwNVVqN3dCZktxSUNpV205cHRwdzA1OUJWNHFZbjlFd3BueTBLZFNVanNnU3E0WGpBS1dGbHV2SG94MTd5b1UyLWtsZ0dCLVNIUEtlRGxnVk9VSmRvWHVOb3l1dTBMay0yaklDd05teHhsS3JSSEV1X3dSaXYxWG1qRS16QTZpR0E?oc=5","date":"2026-03-31","type":"deal","source":"Eli Lilly","summary":"Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | Eli Lilly and Company - Eli Lilly","headline":"Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | Eli Lilly and Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxONDVrVVhsRURoMTc2aEw5SHpmeUF3UDk5YmNPaWFVeDlTU09rVTVlellza1JlRXVreXJaaVFxejJFRHQ0SF9jR28xRmFLR0VWX09seUZUMEJ1U0lTWG03cy15RmNjSXZyczNDazhJUlVGUXpUNmJ1NGFybFMweDNjSDdzVVB2dnBrZG8xc2FwbWsyaEFFQjNFOF9ZV21xTmJCQS11UGNKNkdtdzRYZTlXX1BUVXZSaE5BQzd1ejdPS0E4U2dVV0hEVVpCUS1nTTl1WjFpejM3bkxFcDZ1WTJDbHB1WFI?oc=5","date":"2026-02-12","type":"pipeline","source":"BioSpace","summary":"Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market - BioSpace","headline":"Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOb0xTdko3MGVXTXBfRXROTlhHU21MNlpBWGRQWXp0Y1o4TzVvbDUta1NlYldZdWR5aHdVRTkwOTFJcS1qdnJ1cWNDRWhrN0oxWkhnNTdteUdmekM5YzNFWWF5eFlxZjJmOGxLd3NGcF9ncFlzdU9XclJLM0VYYlY0NzhRbF9vQlR6UW9XYWlIV0RwcDhkMUpGVEUtXzBVV0lqLWJaNV82NlR3dWtRdFRqeVZUUVM?oc=5","date":"2026-01-17","type":"pipeline","source":"fool.co.uk","summary":"Down 22% with a P/E of 9, is Hikma one of the best passive income picks right now? - fool.co.uk","headline":"Down 22% with a P/E of 9, is Hikma one of the best passive income picks right now?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxQR2FkZXM2MHZuWHJ1b2hub1RSQzVPWEpmdkJkWjgzQXFtYnI5VFNBR1pUNnhJY3hMWkg1eGthZW02T1NBLVpVWEIzd0J6WGdIQnZNWHpMZy11ZV9lMC11RWVQN3R2b0RjelJrWkhIQ002dklMcXhob3VZdlJlWWdZa2lySHlSRlZ1MjVzaEhlT1VITVVGdldEUkdnYnpBQzRuTDdnd0FzcksyWVNuTlJ0aUpaZDlUSEtGSjBGMV9TSHIyZS1DcktpaHNmT2JIR3JzVEN5TkVaOHE3bVhScmZQLWoyYlh1OXBPSVFZX0VSOG52RmYxVHFrSFB5OGdjNWVmbVdaajVqYmtraDdIRUx0NHB3?oc=5","date":"2025-12-29","type":"pipeline","source":"Benzinga","summary":"Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Mon - Benzinga","headline":"Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Mon","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-01","type":"earnings","source":"simplywall.st","summary":"Market Cool On Hikma Pharmaceuticals PLC's (LON:HIK) Earnings - simplywall.st","headline":"Market Cool On Hikma Pharmaceuticals PLC's (LON:HIK) Earnings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQLS1rQS1ZLWRHZEE1WWdBTEpWdWlUWDF4MTA5ZzVqZ09SV01hdnZ1OEZWV0xiSEVSLTY2eWU0MjBfdzJNOVRWVWpXamFHUzYzTkNpYm5HamM5SnJNYkZ3Szdmby01UWZVek12TFg0X04xM2ZXcDhkc3NidnpnbWFqUnplM3JiVGRMbzVZV0tDbG5ySm9Qa1E2VldNc08wMzVVNkJwUnVHek1ydEcwVS0tejc2bWkwQlRKb3p3eEZRc2VRX0dBcXRtZEhJRTA?oc=5","date":"2025-11-19","type":"deal","source":"prnewswire.com","summary":"Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc - prnewswire.com","headline":"Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOOUpLb0lDX0tEYzB5WkQ3aHdhQ21QSVR6TnJKU2pUeTkzc1prVllLdnJMS1E4NFNPaU9lSTh4d3RJQUhmb3V4a2V4OFJTT2RrVF9YQy1jVFVaYm9nMGNRdFdjc2l5TkowTndmblJIN2ttT1BmX2dIblZudUkxb3p4d2l5azdqaldwTXNXNnBHeGJKVU9fUVBSSlFkT2pkNWgxWHhxUnBfMVJQUzYtZHRqYzZLTVZvSUVudzFvbDZpT3VXWVk?oc=5","date":"2025-10-28","type":"pipeline","source":"prnewswire.com","summary":"Jazz Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of Directors - prnewswire.com","headline":"Jazz Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPWE9KaFJNMUdqaHR5andqVHRpM19pV25tamZOMEdsQ1cxNXZ0TzYtNmZ2TVAyLTlpa0hMZjlxbkhnYURrcnVobVBWbE5IRXJvaEc3dmdEYlBsZVZPLV9LcVdWVWVXTWw5NFZvMFJsSVluVTRRMXhMWDFGdmhHWDRoc3M3M1VNN29zQnl2N2xWOXpmUDFyRHRXeERHNDhMakhjbE5RcXJnTjdNVlFFdld5aXdya1k5Zw?oc=5","date":"2025-10-24","type":"pipeline","source":"Drug Target Review","summary":"The predictive validity crisis: Pharma’s productivity paradox – Part II - Drug Target Review","headline":"The predictive validity crisis: Pharma’s productivity paradox – Part II","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNUmFvX3lNT05CbXBUdWd2LWQzcTNYcEJvSFZuY3lFNTBnbUdfVTVwc2IzZkRrMHQ2Y0U2Xy1fSHRQWk1zbWZpZjN4azRGLWRpVUw5eTRvVnhTOGdkcmNIemNUYnUwZS1kT1kwSnpKa3M5aU9vendvSnNQYV9wdEJRMVBKTTE5ZjE5QmFYZ1prTHNCczgzWUhVclgwRlFZTklidGk2cTJHWXVmSFlMQWRKWHgydHE?oc=5","date":"2025-10-14","type":"pipeline","source":"Drug Target Review","summary":"The predictive validity crisis: Pharma’s productivity paradox – Part I - Drug Target Review","headline":"The predictive validity crisis: Pharma’s productivity paradox – Part I","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQajBOeFh3UjFKREREdGlQNEkyd1VKMk9Wdmp1aG1aWXZ0bTJrbkJZR3ZTWThJamllOUgwRFBJX1BpSHZ6ZU5yZ3pwV2ItMWdta3MzVDgtZXZkODRYYjVWcXdBTVhSMVJfSVpjVHRMRWdKMU53OGEycmpwX0NIZ0I0UXZoQ1VheTIxbjJhZHpFejVDZF9sVHBqeGphM2I2MnM3elhOZzY1TVBtT3RjM2dseWZjOENtRkFKZ0c3U2wtbW1Oa25ad0hJ?oc=5","date":"2025-10-09","type":"pipeline","source":"MarketBeat","summary":"Weiss Ratings Reaffirms Sell (E+) Rating for Tonix Pharmaceuticals (NASDAQ:TNXP) - MarketBeat","headline":"Weiss Ratings Reaffirms Sell (E+) Rating for Tonix Pharmaceuticals (NASDAQ:TNXP)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOTHI3dHR6c1hoVDE3eTdHY2lmdXE4YV9RNXZWbmVUcExYSTFrUHBFTkl1X1Q5TjBMQTdBaWtsZUxxVEpvSlFWanlmOTJOOGlrTGlpa0NKRkNhSllNYk1MTE5lTEViLWs4SC1mdTBMa3M0Z2J0RWtTcmp0YnI4RUwyT0dtX2ZYbXJ1dW9vNEZYenpGeDROMTRjNEw1YzlMS3NkRURxTUVzai00OXAzQTVHZUYwcjNWWmRlYUJZ?oc=5","date":"2025-10-02","type":"pipeline","source":"Fierce Pharma","summary":"Acadia, e-therapeutics unveil rebrands to better represent their drugmaking missions - Fierce Pharma","headline":"Acadia, e-therapeutics unveil rebrands to better represent their drugmaking missions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQRkdvSlhEeHZxVnZQUmY4QWl0dXZLdDg1TUZaRnYtN3NkNVZUZWx4d2Y2TG4xYmZNRXhJOXpTQklFNjlOQXE5SEg4ZDhpS01QZlRmNnpwVEtjTEpMbEQwQUJmMUFlRU9nZy1sT08wVGptN2lLRFJFd0k5ZWFpZEhIdWRSYmN5TktFaWVqZTRmYWNrZVhjZl9hSWxFd2h1TFk0UXhra09aeUo0UGNqb20xNkZVSmF0M05KTXBZanFaNzZkOGItd0JBRzh1QTRFR2Rpek1MSGhMVzFpZXpRb0E?oc=5","date":"2024-04-10","type":"pipeline","source":"proactiveinvestors.com","summary":"e-Therapeutics plans to delist from AIM after raising £29m from key backers - proactiveinvestors.com","headline":"e-Therapeutics plans to delist from AIM after raising £29m from key backers","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}